Company intelligence / Profile preview

BiotechGo Consulting

Ownership: Private
Development stage: Other

Overview

Provides expert GLP auditing, nonclinical study monitoring, and regulatory strategy for early-stage drug development. Supports clients in achieving IND submissions and early clinical milestones with a focus on cost-effective outsourcing in China/APAC.

Therapeutic areas: Rare DiseasesNeurologyEndocrinologyOncologyImmunology
Modalities: Small moleculePeptidesProtein degrader (PROTACs)RNA therapy (RNA therapeutics)Monoclonal antibody (Antibodies)Recombinant protein (Recombinant proteins)Antibody-drug conjugate (ADCs)Oncolytic virus therapy (Oncolytic viruses)
Industry: Consulting

Beyond the preview

Go deeper on BiotechGo Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiotechGo Consulting.

Explore the full profile